Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

Share Price is delayed by 15 minutes
Get Live Data
1,420.00    4.00 (0.28%)
Bid:
1,426.00
Ask:
1,430.00
Spread: 4.00 (0.281%)
Market Cap: £486.17m
CRW Live PriceLast checked at - London Stock Exchange

Intraday Craneware Share Chart

Significant Contract Win

31 Oct 2017 07:00

RNS Number : 0253V
Craneware plc
31 October 2017
 

Craneware plc

("Craneware", "the Group" or the "Company")

 

Significant Contract Win

 

31 October 2017 - Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, is pleased to announce the renewal and significant expansion of an existing contract with a growing hospital operator in the US.

 

This $6m win sees the extension of a relationship that has been in place since 2007, with the renewal of the customer's existing Value Cycle solutions and the roll out of these same solutions to further facilities that have been recently acquired by this hospital network. The contract is expected to deliver $3.5m of incremental revenue over this new five year term as the hospital network rolls out these solutions at its additional facilities.

 

In accordance with the Company's revenue recognition policy, the majority of the revenue resulting from this contract will be recognised over future periods, adding to the Group's long term visibility of revenue under contract.

 

Keith Neilson, CEO of Craneware plc, commented, "The expansion of this relationship demonstrates the strategic importance of Craneware's Value Cycle solutions to our customers, as they extend their own hospital networks throughout the US. The strength of our solutions and the value they deliver to all customers, including large and complex health systems, allows us to deepen our relationship with our customers as they address the challenges resulting from the continued evolution to the new value based re-imbursement environment.

 

"Having enjoyed our positive working relationship for a decade, we now look forward to continuing to deliver sustainable value throughout this new term."

For further information, please contact:

 

Craneware plc

Peel Hunt

Alma

+44 (0)131 550 3100

+44 (0)20 7418 8900

+44 (0)208 004 4218

Keith Neilson, CEO

Dan Webster

Caroline Forde

Craig Preston, CFO

Adrian Trimmings

George Sellar

Hilary Buchanan

Robyn McConnachie

Josh Royston

 

About Craneware

 

Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.

 

Craneware is the leader in automated value cycle solutions that help US Healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta, Boston and Phoenix employing over 250 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTGMMFGLGLGNZM
Date   Source Headline
7th Dec 20201:11 pmRNSHolding(s) in Company
1st Dec 20201:22 pmRNSHolding(s) in Company
26th Nov 20207:00 amRNSAppointment of Joint Broker
20th Nov 20205:49 pmRNSDividend Currency Election
17th Nov 20201:47 pmRNSHolding(s) in Company
17th Nov 20201:30 pmRNSResult of AGM
17th Nov 20207:00 amRNSAGM Statement
19th Oct 20207:00 amRNSNotice of AGM & Q1 Trading Update
15th Oct 20207:00 amRNSBlock listing Interim Review
2nd Oct 20203:55 pmRNSGrant of Long Term Incentive Plan Awards
21st Sep 20207:00 amRNSFinal Results
18th Aug 20207:00 amRNSPurchase of Shares and Exercise of Share Options
12th Aug 20207:00 amRNSUpdate on Proposed Placing
11th Aug 20205:00 pmRNSProposed Accelerated Bookbuild
8th Jul 20207:00 amRNSTrading Update
18th Jun 20202:37 pmRNSHolding(s) in Company
21st Apr 20205:04 pmRNSGrant of Share Options
20th Apr 202011:05 amRNSSecond Price Monitoring Extn
20th Apr 202011:00 amRNSPrice Monitoring Extension
15th Apr 20205:15 pmRNSBlock listing Interim Review
3rd Apr 20204:36 pmRNSPrice Monitoring Extension
26th Mar 20204:31 pmRNSVesting of Long Term Incentive Plan Award
20th Mar 20202:02 pmRNSDividend Currency Election
20th Mar 20209:00 amRNSBlocklisting Application
3rd Mar 20207:00 amRNSHalf-year Report
24th Feb 20207:00 amRNSBoard Appointments
23rd Jan 20202:05 pmRNSSecond Price Monitoring Extn
23rd Jan 20202:00 pmRNSPrice Monitoring Extension
23rd Jan 20207:00 amRNSTrading Update and Notice of Results
23rd Dec 20193:15 pmRNSDirector/PDMR Shareholding and Total Voting Rights
20th Dec 201912:10 pmRNSHolding(s) in Company
29th Nov 201912:29 pmRNSDividend Currency Election
25th Nov 20195:23 pmRNSHolding(s) in Company
22nd Nov 201911:01 amRNSTotal Voting Rights
18th Nov 20197:00 amRNSShare Purchase by Chairman Designate
13th Nov 20194:10 pmRNSResult of AGM
12th Nov 20197:00 amRNSAGM Statement
16th Oct 201910:46 amRNSBlock listing Interim Review
11th Oct 20194:17 pmRNSPosting of Annual Report and Notice of AGM
3rd Oct 20194:41 pmRNSSecond Price Monitoring Extn
3rd Oct 20194:35 pmRNSPrice Monitoring Extension
18th Sep 20197:00 amRNSDirector/PDMR Shareholding
16th Sep 201912:03 pmRNSHolding(s) in Company
4th Sep 20196:14 pmRNSGrant of Long Term Incentive Plan Awards
3rd Sep 20197:00 amRNSFinal Results
2nd Sep 201911:23 amRNSBlocklisting Application
1st Jul 20192:00 pmRNSPrice Monitoring Extension
28th Jun 20199:05 amRNSSecond Price Monitoring Extn
28th Jun 20199:00 amRNSPrice Monitoring Extension
28th Jun 20197:00 amRNSTrading Update and Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.